REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 67 filers reported holding REPARE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,044,552 | +5.5% | 1,079,847 | -7.6% | 0.00% | 0.0% |
| Q2 2023 | $12,361,746 | -31.8% | 1,168,407 | -36.6% | 0.00% | 0.0% |
| Q1 2023 | $18,124,158 | +40.6% | 1,841,886 | +110.2% | 0.00% | 0.0% |
| Q4 2022 | $12,888,578 | +499.5% | 876,178 | +394.4% | 0.00% | – |
| Q3 2022 | $2,150,000 | -88.8% | 177,230 | -87.1% | 0.00% | -100.0% |
| Q2 2022 | $19,242,000 | -54.0% | 1,375,388 | -53.2% | 0.00% | -33.3% |
| Q1 2022 | $41,863,000 | -34.3% | 2,939,823 | -2.7% | 0.00% | -40.0% |
| Q4 2021 | $63,720,000 | -12.8% | 3,021,313 | +8.5% | 0.01% | -16.7% |
| Q3 2021 | $73,046,000 | -15.6% | 2,783,776 | +0.3% | 0.01% | -14.3% |
| Q2 2021 | $86,526,000 | +1.9% | 2,775,053 | +0.3% | 0.01% | 0.0% |
| Q1 2021 | $84,944,000 | -10.2% | 2,767,833 | +0.4% | 0.01% | -12.5% |
| Q4 2020 | $94,577,000 | +11.5% | 2,757,375 | +0.0% | 0.01% | -11.1% |
| Q3 2020 | $84,817,000 | +8.2% | 2,756,509 | +9.1% | 0.01% | 0.0% |
| Q2 2020 | $78,401,000 | – | 2,527,453 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |